A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to PCNSL
Related studies linked through entity extraction aliases.
A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:
- Status
- COMPLETED
- Phase
- N/A
A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
- Status
- RECRUITING
- Phase
- PHASE2
Real World Data on Ibrutinib Use in PCNSL Rel/Ref
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL
- Status
- UNKNOWN
- Phase
- PHASE2
Bendamustine-based Combination Therapy for PCNSL
- Status
- UNKNOWN
- Phase
- PHASE2